International Chemical Investors Group
  • HOME
  • OUR APPROACH
  • OUR INVESTMENTS
    • Market Oriented Platforms
    • Companies
  • NEWS
  • CONTACT

ICIG announces the appointment of Dr. Michael Quirmbach as CEO & President of CordenPharma Group

by Infrastructure Support | Jul 26, 2019 | News

26. July 2019 CordenPharma Group, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is pleased to announce the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective...

LATEST ICIG NEWS

Astorg to acquire leading Pharmaceutical Contract Development & Manufacturing Organization CordenPharma from ICIG

May 2nd, 2022 – Basel Astorg and International Chemical Investors Group (“ICIG”) today announce that they have signed a binding agreement whereby Astorg will acquire...

ICIG Business Services certified according to ISO 27001

29 March 2022 ICIG Business Services, the shared service center within the International Chemical Investors Group (ICIG), has successfully achieved its ISO 27001...

Vynova reduces carbon footprint of Tessenderlo site with hydrogen-fired steam boilers

16 March 2022 Vynova, a leading European PVC and chlor-alkali company, has inaugurated a state-of-the-art hydrogen-fired steam boiler system at its site in Tessenderlo,...

Vynova launches world’s first low-carbon potassium derivatives portfolio

23 February 2022 Vynova has launched the world’s first range of low-carbon potassium (K) derivatives. Marketed under the VynoEcoSolutions brand, the new K derivatives...

⤏ All News